Browse the detailed record of transactions filed by 이영미, Directeur. Insider active across 2 companies, notably 명문제약. Aggregated, 13 disclosures have been published. The latest transaction was disclosed on 30 April 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Lee Youngmi is a Director at Myungmoon Pharmaceutical, a company specializing in the pharmaceutical sector. She is responsible for overseeing operations and ensuring compliance with quality standards. Myungmoon Pharmaceutical is known for its innovative products and commitment to public health. Lee Youngmi plays a key role in the company's development strategy.